chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Diagnosed with shingles on 4/13, first noticed rash on stomach on April 11; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 30Mar2021 at 16:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient was not allergic to medications, food, or other products. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1686) via an unspecified route of administration in the left arm on 05Mar2021 at 12:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 08:00, twelve days after second dose of vaccination, the patient first noticed rash on stomach. On 13Apr2021, the patient was diagnosed with shingles. The patient had no other intervening health changes or issues between time of second vaccine and onset of shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles which included treatment with valacyclovir 1 gram for 10 days. The clinical outcome of the event shingles was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Itching Rash; This is a spontaneous report from a contactable nurse. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PAA165969) via an intramuscular route of administration in the right arm on 01Apr2021 at 11:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included end stage renal disease (ESRD). The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 02Apr2021, the patient experienced itching rash. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the event which included treatment with antihistamine (unspecified) and cortisone cream (MANUFACTURER UNKNOWN). The clinical outcome of event itching rash was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion
Clinical narrative: Weird bruise on arm for a week after the first shot; This is a spontaneous report from a contactable healthcare professional. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8737) via an unspecified route of administration in the left arm on 25Mar2021 at 15:30 (at the age of 27-year-old) and second dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8737) via an unspecified route of administration in the left arm on 21Apr2021 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT), medroxyprogesterone acetate (DEPO PROVERA), gabapentin (MANUFACTURER UNKNOWN) and oxcarbazepine (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient had no known allergies. On 25Mar2021 at 15:30, the patient experienced weird bruise on her arm for a week after the first shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event weird bruise on arm for a week after the first shot was recovered on an unknown date in Apr2021.    No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Fatigue, Headache, Pain in extremity, Pyrexia
Clinical narrative: Upset stomach; Slight fever; Headache; Tiredness; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8734) via an unspecified route of administration in the left arm on 21Apr2021 at 14:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to pineapple and walnuts. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included citalopram hydrobromide (CELEXA), trazodone (MANUFACTURER UNKNOWN), loratadine (CLARITIN), fish oil (MANUFACTURER UNKNOWN) and unspecified birth control medication; all for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 31Mar2021 at 14:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 07:00, the patient experienced slight fever, headache, upset stomach, tiredness and sore arm. The events did not result in doctor or other health care professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events slight fever, headache, upset stomach, tiredness and sore arm were resolving at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Pyrexia
Clinical narrative: Dizziness; Fever; Vomiting; Headache; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 21Apr2021 at 12:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any vaccination within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via unspecified route of administration in the left arm on 31Mar2021 (at the age of 23-year-old) at 12:00 as a single dose for COVID-19 immunisation. On 21Apr2021 at 20:00 the patient experienced dizziness, fever, vomiting, headache, chills and fatigue. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of these events. The clinical outcome of the events dizziness, fever, vomiting, headache, chills and fatigue were not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Dizziness; Fever; Vomiting; Headache; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 21Apr2021 at 12:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any vaccination within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via unspecified route of administration in the left arm on 31Mar2021 (at the age of 23-year-old) at 12:00 as a single dose for COVID-19 immunisation. On 21Apr2021 at 20:00 the patient experienced dizziness, fever, vomiting, headache, chills and fatigue. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of these events. The clinical outcome of the events dizziness, fever, vomiting, headache, chills and fatigue were not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Bad rash all over body; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 08:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Allergies to medications, food, or other products was reported as Not Applicable. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included hydrocodone (MANUFACTURER UNKNOWN), ibuprofen (MANUFACTURER UNKNOWN), tamsulosin (MANUFACTURER UNKNOWN) and metoprolol (MANUFACTURER UNKNOWN), all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 08:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 09:30, the patient experienced bad rash all over body. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of bad rash all over body. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event bad rash all over body was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Hyperhidrosis, Oropharyngeal pain, Pyrexia, Vaccination site pain
Clinical narrative: Sore throat; Sweats; 100.1 fever; Pain at injection sight; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on 21Apr2021 at 09:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included kato dietary supplement which was unspecified from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 22Apr2021 at 04:00, the patient experienced 100.1 (units unspecified) fever, sweats, pain at injection sight and sore throat. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events 100.1 (units unspecified) fever, sweats, pain at injection sight and sore throat was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, SARS-CoV-2 test
Clinical narrative: Itching sensation on palms and feet; Redness; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the left arm on 20Apr2021 at 14:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included lichen planus rash history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medication included amoxicillin; clavulanic acid (AUGMENTIN) 875mg/125mg for 12days (04Apr-17Apr). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the left arm on 30Mar2021 at 12:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination.  Since the vaccination, the patient had been tested for COVID-19. On 08Apr2021, the patient underwent a RT PCR (real time reverse transcription-polymerase chain reaction) (nasal swab) test and tested negative. On 21Apr2021 at 13:00, the patient experienced itching sensation on palms and feet. He had no rash yet, but could see some redness. The events did not result in a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with loratadine (CLARITIN) or cetirizine hydrochloride (ZYRTEC) OTC (over the counter) medicine, as needed. The clinical outcome of the event itching sensation on palms and feet and redness was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Oral blood blister
Clinical narrative: Two blood blisters on inside of left cheek; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 20Apr2021 at 15:45 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paracetamol (TYLENOL) for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8734) via an unspecified route of administration in the left arm on 27Mar2021 at 10:30 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. On 22Apr2021 at 12:15, the patient experienced two blood blisters on inside of left cheek which were not painful. Since the vaccination, the patient had not been tested for COVID-19. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event two blood blisters on inside of left cheek was unknown at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on face and neck; Rash on face and neck; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO158) via an unspecified route of administration in the left arm on 19Apr2021 at 10:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included Rheumatoid Arthritis (RA), lupus and Multiple Endocrine Neoplasia (MEN) type 1. The patient was allergic to contrast dye. Concomitant medications included levothyroxine sodium (SYNTHROID), rosuvastatin calcium (XELL), carvedilol (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN) and benazepril (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FR8733) via an unspecified route of administration in the left arm on 29Mar2021 at 10:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 07:00, after the shot, the patient experienced rash on face and neck which lasted for several days. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event rash on face and neck was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Eye pain, Feeling hot, Nausea
Clinical narrative: Body ache; Nauseous; Eye pain; Joint pain; Chills; hot; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Apr2021 at 16:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. The patient did not have any allergies to medications, food or other products. The patient did not receive any other mediations within two weeks prior to vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 03:00, the patient experienced body ache, nauseous, eye pain, joint pain, chills and hot. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events body ache, nauseous, eye pain, joint pain, chills and hot were resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Body ache; Nauseous; Eye pain; Joint pain; Chills; hot; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Apr2021 at 16:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. The patient did not have any allergies to medications, food or other products. The patient did not receive any other mediations within two weeks prior to vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 03:00, the patient experienced body ache, nauseous, eye pain, joint pain, chills and hot. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events body ache, nauseous, eye pain, joint pain, chills and hot were resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, SARS-CoV-2 test
Clinical narrative: having a horrible rash all over my body; Very itchy; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Mar2021 at 03:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation.  The patient did not have any relevant medical history. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination (didn't take any medications before 1 dose reported by patient). The patient did not receive any other vaccines within four weeks  prior to the vaccination. On 11Mar2021 the patient experienced having a horrible rash all over her body and very itchy. The event resulted in doctor or other healthcare professional office/clinic visit. On 24Mar2021, the patient underwent Nasal Swab, SARS CoV-2 test  and the result was Negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event having a horrible rash all over her body, very itchy were not resolved at the time of the report.  The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 03:45 (at the age of 50-year-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Feeling cold, Pyrexia, Tremor
Clinical narrative: All of a sudden got super cold; had some back pain; Felt a little shaky; fever; This is a spontaneous report from a contactable consumer, the patient. A 18-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6207) via an unspecified route of administration in the right arm on 21Apr2021 at 10:15 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. Medical history included unspecified allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol, norgestrel (LOW-OGESTREL) and fexofenadine hydrochloride (ALLEGRA) both for unknown indications on unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN5318) via an unspecified route of administration in the right arm on 31Mar2021 at 10:15 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 21:30, all of a sudden, the patient experienced super cold, some back pain, felt a little shaky and fever.  On 21Apr2021, the patient felt little shaky so checked her body temperature and the result was 100.5 degree Farenheit (degF). On 21Apr2021, fever reached 102.5 (degF) during the night. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events super cold, some back pain, felt a little shaky and fever was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Aphthous ulcer, Discomfort, Dysphagia, Dysphonia, Eating disorder
Clinical narrative: Throat got swollen; difficult to swallow; sore throat; scratchy voice; Red nickel-sized circle around shot site (kind of like a rash/ bug bite look); sore arm; 3 large canker sores; couldn't eat for days; feverish symptoms; Pain; discomfort; very tired; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER8735) via an unspecified route of administration in the  right arm on 04Apr2021 at 15:30(at the age of 19-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient was allergic to  house dust mite allergy, pollen allergy, oak, pine dairy intolerance, gluten intolerance, soy allergy, peanut allergy, seafood allergy, allergic to birds and allergy to animals(dogs, cats). Concomitant medications included ibuprofen (ADVIL)  when needed and allergy medicine daily  from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 20:00, the patient experienced throat got swollen a few hours after receiving vaccine, difficult to swallow for 2-3 days after sore throat & scratchy voice, red nickel-sized circle around shot site (kind of like a rash/ bug bite look) and sore arm, 3 large canker sores in the side of the mouth lasting two weeks and could not eat for days because of the pain, feverish symptoms, discomfort, very tired and sluggish. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event throat got swollen, difficult to swallow, sore throat, scratchy voice red rash and sore arm, canker sores, pain, feverish symptoms, discomfort, very tired and sluggish was recovering at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Oropharyngeal pain, Pain, Pain in extremity, Pharyngeal swelling
Clinical narrative: Throat got swollen; difficult to swallow; sore throat; scratchy voice; Red nickel-sized circle around shot site (kind of like a rash/ bug bite look); sore arm; 3 large canker sores; couldn't eat for days; feverish symptoms; Pain; discomfort; very tired; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER8735) via an unspecified route of administration in the  right arm on 04Apr2021 at 15:30(at the age of 19-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient was allergic to  house dust mite allergy, pollen allergy, oak, pine dairy intolerance, gluten intolerance, soy allergy, peanut allergy, seafood allergy, allergic to birds and allergy to animals(dogs, cats). Concomitant medications included ibuprofen (ADVIL)  when needed and allergy medicine daily  from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 20:00, the patient experienced throat got swollen a few hours after receiving vaccine, difficult to swallow for 2-3 days after sore throat & scratchy voice, red nickel-sized circle around shot site (kind of like a rash/ bug bite look) and sore arm, 3 large canker sores in the side of the mouth lasting two weeks and could not eat for days because of the pain, feverish symptoms, discomfort, very tired and sluggish. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event throat got swollen, difficult to swallow, sore throat, scratchy voice red rash and sore arm, canker sores, pain, feverish symptoms, discomfort, very tired and sluggish was recovering at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash erythematous
Clinical narrative: Throat got swollen; difficult to swallow; sore throat; scratchy voice; Red nickel-sized circle around shot site (kind of like a rash/ bug bite look); sore arm; 3 large canker sores; couldn't eat for days; feverish symptoms; Pain; discomfort; very tired; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER8735) via an unspecified route of administration in the  right arm on 04Apr2021 at 15:30(at the age of 19-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient was allergic to  house dust mite allergy, pollen allergy, oak, pine dairy intolerance, gluten intolerance, soy allergy, peanut allergy, seafood allergy, allergic to birds and allergy to animals(dogs, cats). Concomitant medications included ibuprofen (ADVIL)  when needed and allergy medicine daily  from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 20:00, the patient experienced throat got swollen a few hours after receiving vaccine, difficult to swallow for 2-3 days after sore throat & scratchy voice, red nickel-sized circle around shot site (kind of like a rash/ bug bite look) and sore arm, 3 large canker sores in the side of the mouth lasting two weeks and could not eat for days because of the pain, feverish symptoms, discomfort, very tired and sluggish. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event throat got swollen, difficult to swallow, sore throat, scratchy voice red rash and sore arm, canker sores, pain, feverish symptoms, discomfort, very tired and sluggish was recovering at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Erythema, Pruritus, Swelling, Vaccination site bruising
Clinical narrative: Large red swollen itchy patch on upper arm below injection site; Large red swollen itchy patch on upper arm below injection site; Large red swollen itchy patch on upper arm below injection site; Now turning into a bruise.; Bruise at injection site.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 16Apr2021 at 15:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN) and multivitamins; all from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 18Apr2021, the patient experienced large red swollen itchy patch on upper arm below injection site. It turned into a bruise and also bruise at injection site on an unknown date in Apr2021. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of event large red swollen itchy patch on upper arm below injection site; turned into a bruise and bruise at injection site were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Left axilla soft tissue swelling; This is a spontaneous report from a contactable physician. A 39-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included back pain and COVID-19. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19, on an unknown date. Concomitant medications included diclofenac (MANUFACTURER UNKNOWN) from an unknown date for unspecified indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 08:00, the patient experienced left axilla soft tissue swelling. Therapeutic measures were taken as a result of adverse events and included treatment with antibiotics.  Since the vaccination, the patient had not been tested for COVID-19.  The event resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event left axilla soft tissue swelling was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dysphagia, Ear pain, Headache, Middle ear effusion
Clinical narrative: fever; body ache; sore throat; headache; swollen tonsils; ear hurt; difficult to swallow; have fluid on my ears; This is a spontaneous report from a contactable healthcare professional. A 21-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on an unknown date as a single dose for COVID-19immunisation. Concomitant medications included ivabradine hydrochloride (CORLANOR) ,birth control  for unknown indication on an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.Since the vaccination, the patient had been tested for COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 two days after the vaccination the patient experienced  fever, body aches, sore throat, head ache and three days after vaccine she had swollen tonsils, fever, sever body aches, ears hurt. Now 4 days after she have been to the doctor and they said  having a bad viral response to the vaccine, tonsils are swollen and have white spots, temperature is 103, body hurts, hardly swallow anything and  have fluid on her  ears. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. On an unknown date, the patient underwent body temperature examination and the result was 103. On 19Apr2021, the patient underwent COVID-19 test (Nasal Swab) and the result was negative.  The clinical outcome of the event fever,  body ache, sore throat, headache, swollen tonsil ,ear hurt and fluid in ear was unknown.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test, Tonsillar hypertrophy
Clinical narrative: fever; body ache; sore throat; headache; swollen tonsils; ear hurt; difficult to swallow; have fluid on my ears; This is a spontaneous report from a contactable healthcare professional. A 21-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on an unknown date as a single dose for COVID-19immunisation. Concomitant medications included ivabradine hydrochloride (CORLANOR) ,birth control  for unknown indication on an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.Since the vaccination, the patient had been tested for COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 two days after the vaccination the patient experienced  fever, body aches, sore throat, head ache and three days after vaccine she had swollen tonsils, fever, sever body aches, ears hurt. Now 4 days after she have been to the doctor and they said  having a bad viral response to the vaccine, tonsils are swollen and have white spots, temperature is 103, body hurts, hardly swallow anything and  have fluid on her  ears. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. On an unknown date, the patient underwent body temperature examination and the result was 103. On 19Apr2021, the patient underwent COVID-19 test (Nasal Swab) and the result was negative.  The clinical outcome of the event fever,  body ache, sore throat, headache, swollen tonsil ,ear hurt and fluid in ear was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: "Minutes after I take the vaccine, i feel numbness on my face.m, it last over 8 hours".; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 18Apr2021 at 14:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included season allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included ethinylestradiol, norethisterone acetate (JUNEL FE 1.5/30) taken for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 18Apr2021 at 14:45, minutes after she took the vaccine, she felt numbness on her "face.m". It lasted over 8 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event numbness on "face.m" was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Decreased appetite, Dizziness
Clinical narrative: Dizzy; by the time I got up on tue. I had the shakes,; Nausea; when I tried to eat I threw up,; can feel my lymph nodes are slightly swollen,; as well as Joint pain,; Chills; Muscle pain; One day after the shot my arm felt like I had just received a tetnis shot. I got the shot 17 apr a sat. by monday I was feeling weak; Slept for 24 hours; Have eat on once since Sunday; Weight has dropped from 185 to 172.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: 59267-1000-01) via an unspecified route of administration in the left arm on 17Apr2021 at 09:15 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included recovery from heroin addiction from past 26 months and allergy to penicillin and its relatives. Prior to the vaccination, the patient was not  diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included clindamycin (MANUFACTURER UNKNOWN) for unknown indication on unknown date and unknown if ongoing. On 19Apr2021, one day after the shot, the patient arm felt like receiving a tetanus shot and weak, so he layed down and slept for 24 hours. On 20Apr2021, the next day, by the time the patient got up experienced shakes, was dizzy, had nausea, when he tried to eat he threw up, lymph nodes were slightly swollen, as well as joint pain, chills, and muscle pain. On 21Apr2021, on the next day, it was worse. On 22Apr2021, after a day, the patient felt slightly better. The patient reported that he was in contact with doctor and was told to rest, take tylenol and if symptoms get worsened then to go to the emergency room. The patient was resting, but have eaten only once since 18Apr2021, the day after vaccine. The patient weight had dropped from 185 to 172 (unspecified units). The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm felt like had just received a tetanus shot and felt weak, layed down and slept for 24 hours, shakes, was dizzy, had nausea, threw up, lymph nodes slightly swollen, joint pain, chills, muscle pain and weight dropped from 185 to 172 (unspecified units) was resolved with sequelae on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersomnia, Lymphadenopathy, Myalgia, Nausea, Tremor
Clinical narrative: Dizzy; by the time I got up on tue. I had the shakes,; Nausea; when I tried to eat I threw up,; can feel my lymph nodes are slightly swollen,; as well as Joint pain,; Chills; Muscle pain; One day after the shot my arm felt like I had just received a tetnis shot. I got the shot 17 apr a sat. by monday I was feeling weak; Slept for 24 hours; Have eat on once since Sunday; Weight has dropped from 185 to 172.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: 59267-1000-01) via an unspecified route of administration in the left arm on 17Apr2021 at 09:15 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included recovery from heroin addiction from past 26 months and allergy to penicillin and its relatives. Prior to the vaccination, the patient was not  diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included clindamycin (MANUFACTURER UNKNOWN) for unknown indication on unknown date and unknown if ongoing. On 19Apr2021, one day after the shot, the patient arm felt like receiving a tetanus shot and weak, so he layed down and slept for 24 hours. On 20Apr2021, the next day, by the time the patient got up experienced shakes, was dizzy, had nausea, when he tried to eat he threw up, lymph nodes were slightly swollen, as well as joint pain, chills, and muscle pain. On 21Apr2021, on the next day, it was worse. On 22Apr2021, after a day, the patient felt slightly better. The patient reported that he was in contact with doctor and was told to rest, take tylenol and if symptoms get worsened then to go to the emergency room. The patient was resting, but have eaten only once since 18Apr2021, the day after vaccine. The patient weight had dropped from 185 to 172 (unspecified units). The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm felt like had just received a tetanus shot and felt weak, layed down and slept for 24 hours, shakes, was dizzy, had nausea, threw up, lymph nodes slightly swollen, joint pain, chills, muscle pain and weight dropped from 185 to 172 (unspecified units) was resolved with sequelae on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.